0.0011
-0.0004
(-26.67%)
At close: 10:04:43 AM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. | CEO & Chairman | 37.63k | -- | 1973 |
| Dr. Riva Kovjazin M.D. | Senior Scientist & Member of Scientific Advisory Board | -- | -- | -- |
Vaxil Bio Ltd.
3400 One First Canadian Place
Toronto, ON M5X 1A4
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidate. The company was founded in 2006 and is headquartered in Toronto, Canada.
Corporate Governance
Vaxil Bio Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
INTI Inhibitor Therapeutics, Inc.
0.0470
0.00%
ZHCLF Zenith Capital Corp.
0.0500
0.00%
NRXPW NRx Pharmaceuticals, Inc.
0.0619
+3.17%
CNBX CNBX Pharmaceuticals Inc.
0.0100
+40.85%
RVX.TO Resverlogix Corp.
0.0400
0.00%
BIXT Bioxytran, Inc.
0.1898
+11.65%
KTTAW Pasithea Therapeutics Corp.
0.0199
-33.44%
PYPD PolyPid Ltd.
2.4800
-0.60%
TCRX TScan Therapeutics, Inc.
1.2400
+9.73%
NGEN.V NervGen Pharma Corp.
2.8100
+0.36%